EGFR and prostate carcinoma: In PTEN-negative prostate cancer cells, the disassembly of HDs leads to the association of plectin with actin-rich focal adhesions, which results in the activation of the EGFR/PI3K/Akt and FAK/Src pathways to promote tumor progression [41].